Microbot Medical Inc (MBOT) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.068x

Based on the latest financial reports, Microbot Medical Inc (MBOT) has a cash flow conversion efficiency ratio of -0.068x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.05 Million) by net assets ($74.11 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MBOT defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Microbot Medical Inc - Cash Flow Conversion Efficiency Trend (1991–2025)

This chart illustrates how Microbot Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Microbot Medical Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Microbot Medical Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Value Valves Co Ltd
TWO:4580
0.051x
Mostostal Zabrze - Holding SA
WAR:MSZ
-0.083x
CYGNUS Metals Ltd
AU:CY5
-0.033x
Central Proteina Prima Tbk
JK:CPRO
0.013x
FELIX Gold Ltd
AU:FXG
-0.022x
Maywood Acquisition Corp. Class A Ordinary Shares
NASDAQ:MAYA
-0.002x
Glintt
LS:GLINT
0.004x
Ambra SA
WAR:AMB
-0.005x

Annual Cash Flow Conversion Efficiency for Microbot Medical Inc (1991–2025)

The table below shows the annual cash flow conversion efficiency of Microbot Medical Inc from 1991 to 2025. For the full company profile with market capitalisation and key ratios, see MBOT company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $77.55 Million $-13.05 Million -0.168x +93.27%
2024-12-31 $3.53 Million $-8.83 Million -2.501x -31.90%
2023-12-31 $4.50 Million $-8.53 Million -1.896x -19.65%
2022-12-31 $7.29 Million $-11.55 Million -1.584x -143.59%
2021-12-31 $14.38 Million $-9.35 Million -0.650x -118.02%
2020-12-31 $24.31 Million $-7.25 Million -0.298x -45.86%
2019-12-31 $31.54 Million $-6.45 Million -0.205x +94.88%
2018-12-31 $1.33 Million $-5.31 Million -3.992x -719.22%
2017-12-31 $9.96 Million $-4.86 Million -0.487x -5.16%
2016-12-31 $1.70 Million $-786.00K -0.463x -120.23%
2015-12-31 $-334.00K $-765.00K 2.290x +149.16%
2014-12-31 $5.87 Million $-27.35 Million -4.659x -198.73%
2013-12-31 $14.95 Million $-23.32 Million -1.560x -9.77%
2012-12-31 $13.98 Million $-19.87 Million -1.421x +30.92%
2011-12-31 $10.73 Million $-22.06 Million -2.057x -29.85%
2010-12-31 $15.48 Million $-24.52 Million -1.584x -95.69%
2009-12-31 $30.50 Million $-24.68 Million -0.809x +22.38%
2008-12-31 $21.81 Million $-22.74 Million -1.043x -76.04%
2007-12-31 $35.21 Million $-20.86 Million -0.592x -100.00%
2006-12-31 $54.38 Million $-16.10 Million -0.296x +19.23%
2005-12-31 $32.38 Million $-11.87 Million -0.367x -20.17%
2004-12-31 $36.95 Million $-11.27 Million -0.305x +60.84%
2003-12-31 $10.96 Million $-8.54 Million -0.779x +70.74%
2002-12-31 $3.79 Million $-10.09 Million -2.663x -234.50%
2001-12-31 $13.21 Million $-10.52 Million -0.796x -189.61%
2000-12-31 $22.98 Million $-6.32 Million -0.275x +92.28%
1999-12-31 $3.51 Million $-12.49 Million -3.562x -593.02%
1998-12-31 $17.90 Million $-9.20 Million -0.514x -7.64%
1997-12-31 $28.90 Million $-13.80 Million -0.478x -65.70%
1996-12-31 $34.70 Million $-10.00 Million -0.288x -227.09%
1995-12-31 $45.40 Million $-4.00 Million -0.088x +85.14%
1994-12-31 $22.60 Million $-13.40 Million -0.593x -71.90%
1993-12-31 $34.50 Million $-11.90 Million -0.345x -13.17%
1992-12-31 $29.20 Million $-8.90 Million -0.305x +10.95%
1991-12-31 $14.90 Million $-5.10 Million -0.342x --

About Microbot Medical Inc

NASDAQ:MBOT USA Medical Instruments & Supplies
Market Cap
$126.27 Million
Market Cap Rank
#18581 Global
#4249 in USA
Share Price
$1.88
Change (1 day)
+3.30%
52-Week Range
$1.62 - $4.50
All Time High
$891.00
About

Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, periph… Read more